ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	7/72	79/7206	1.20875503833e-05
ko04060	Cytokine-cytokine receptor interaction	9/72	191/7206	0.000107591139293
ko04657	IL-17 signaling pathway	6/72	87/7206	0.000214896963817
ko04510	Focal adhesion	9/72	240/7206	0.000591737561957
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	5/72	79/7206	0.00109898798553
ko00590	Arachidonic acid metabolism	4/72	52/7206	0.00172736481187
ko05146	Amoebiasis	5/72	99/7206	0.00298971723125
ko05410	Hypertrophic cardiomyopathy (HCM)	5/72	100/7206	0.00312296129118
ko04810	Regulation of actin cytoskeleton	8/72	264/7206	0.00458428559207
ko05414	Dilated cardiomyopathy	5/72	112/7206	0.00507467321307
ko04666	Fc gamma R-mediated phagocytosis	5/72	122/7206	0.00726228546307
ko05206	MicroRNAs in cancer	6/72	177/7206	0.00825140946805
ko05222	Small cell lung cancer	4/72	89/7206	0.01181721027
ko04151	PI3K-Akt signaling pathway	9/72	390/7206	0.0150163879813
ko04670	Leukocyte transendothelial migration	5/72	151/7206	0.0171745287439
ko04640	Hematopoietic cell lineage	3/72	64/7206	0.0258096815597
ko05145	Toxoplasmosis	4/72	126/7206	0.0368467790602
ko05140	Leishmaniasis	3/72	75/7206	0.0387226330183
ko04514	Cell adhesion molecules (CAMs)	4/72	130/7206	0.0406039952299
ko04370	VEGF signaling pathway	3/72	77/7206	0.041365462944
ko04933	AGE-RAGE signaling pathway in diabetic complications	4/72	135/7206	0.0455979555988